Back to Search Start Over

Autologous Marrow Mesenchymal Stem Cell Driving Bone Regeneration in a Rabbit Model of Femoral Head Osteonecrosis.

Authors :
Mastrolia, Ilenia
Giorgini, Andrea
Murgia, Alba
Loschi, Pietro
Petrachi, Tiziana
Rasini, Valeria
Pinelli, Massimo
Pinto, Valentina
Lolli, Francesca
Chiavelli, Chiara
Grisendi, Giulia
Baschieri, Maria Cristina
Santis, Giorgio De
Catani, Fabio
Dominici, Massimo
Veronesi, Elena
Source :
Pharmaceutics; Oct2022, Vol. 14 Issue 10, pN.PAG-N.PAG, 16p
Publication Year :
2022

Abstract

Osteonecrosis of the femoral head (ONFH) is a progressive degenerative disease that ultimately requires a total hip replacement. Mesenchymal stromal/stem cells (MSCs), particularly the ones isolated from bone marrow (BM), could be promising tools to restore bone tissue in ONFH. Here, we established a rabbit model to mimic the pathogenic features of human ONFH and to challenge an autologous MSC-based treatment. ON has been originally induced by the synergic combination of surgery and steroid administration. Autologous BM-MSCs were then implanted in the FH, aiming to restore the damaged tissue. Histological analyses confirmed bone formation in the BM-MSC treated rabbit femurs but not in the controls. In addition, the model also allowed investigations on BM-MSCs isolated before (ON-BM-MSCs) and after (ON+BM-MSCs) ON induction to dissect the impact of ON damage on MSC behavior in an affected microenvironment, accounting for those clinical approaches foreseeing MSCs generally isolated from affected patients. BM-MSCs, isolated before and after ON induction, revealed similar growth rates, immunophenotypic profiles, and differentiation abilities regardless of the ON. Our data support the use of ON+BM-MSCs as a promising autologous therapeutic tool to treat ON, paving the way for a more consolidated use into the clinical settings. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
19994923
Volume :
14
Issue :
10
Database :
Complementary Index
Journal :
Pharmaceutics
Publication Type :
Academic Journal
Accession number :
159942104
Full Text :
https://doi.org/10.3390/pharmaceutics14102127